ketotifen has been researched along with Cafe-au-Lait Spots with Pulmonic Stenosis in 9 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Plexiform neurofibromas are either diffuse or nodular, the latter form being much more frequent." | 1.29 | [Exclusive nodular plexiform neurofibroma. An unusual case of neurofibromatosis type 1]. ( Benchikhi, H; Revuz, J; Vidaud, D; Wechsler, J; Wolkenstein, P; Zeller, J, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riccardi, VM | 2 |
| Rodriguez-Jimenez, P | 1 |
| Chicharro, P | 1 |
| Muñoz, E | 1 |
| Dauden, E | 1 |
| Meyer, LJ | 1 |
| Benchikhi, H | 1 |
| Zeller, J | 1 |
| Wolkenstein, P | 1 |
| Wechsler, J | 1 |
| Vidaud, D | 1 |
| Revuz, J | 1 |
| Krause, L | 1 |
| Haustein, UF | 1 |
| Claman, HN | 1 |
| Lehrer, JF | 1 |
1 trial available for ketotifen and Cafe-au-Lait Spots with Pulmonic Stenosis
| Article | Year |
|---|---|
Mast-cell stabilization to decrease neurofibroma growth. Preliminary experience with ketotifen.
Topics: Adolescent; Adult; Child; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Ketotifen; Ma | 1987 |
8 other studies available for ketotifen and Cafe-au-Lait Spots with Pulmonic Stenosis
| Article | Year |
|---|---|
Ketotifen suppression of NF1 neurofibroma growth over 30 years.
Topics: Administration, Oral; Adult; Female; Genes, Neurofibromatosis 1; Humans; Ketotifen; Male; Mast Cells | 2015 |
Long-term treatment of neurofibromatosis 1 with ketotifen. A report of three cases.
Topics: Adult; Female; Humans; Ketotifen; Male; Neurofibromatosis 1; Phenotype; Skin; Time Factors; Treatmen | 2016 |
Drug therapy for neurofibromatosis?
Topics: Humans; Ketotifen; Neurofibromatosis 1; Pruritus | 1993 |
[Exclusive nodular plexiform neurofibroma. An unusual case of neurofibromatosis type 1].
Topics: Adolescent; Humans; Hypertrophy; Ketotifen; Male; Neck; Neurofibroma, Plexiform; Neurofibromatosis 1 | 1995 |
Ketotifen and neurofibromatosis.
Topics: Histamine Release; Humans; Ketotifen; Mast Cells; Neurofibromatosis 1 | 1988 |
[Ketotifen inhibits urticaria and tumor progression in neurofibromatosis].
Topics: Administration, Oral; Humans; Ketotifen; Neurofibromatosis 1; Skin Neoplasms; Urticaria | 1989 |
New hope for neurofibromatosis? The mast cell connection.
Topics: Humans; Ketotifen; Mast Cells; Neurofibromatosis 1 | 1987 |
Chemotherapy of bilateral acoustic neuromas.
Topics: Humans; Ketotifen; Neurofibromatosis 1; Neuroma, Acoustic | 1988 |